Established in 1969, our UK facility has had many name changes and focuses over the years, culminating in the launch of Sterling Pharma Solutions in 2016. As a well-established CDMO, with specialist expertise in handling complex chemistries, we bring over 50 years’ experience in contract development, and manufacturing to the global pharmaceutical industry.

Over the years additional facilities have been added to our portfolio and we have continued to invest in our capabilities.Today, our facilities span both the UK and US and our team now includes over 400 talented individuals dedicated to offering our customers first-class API services and cGMP contract development manufacturing capabilities.

In this video our CEO, Kevin Cook, gives an overview of the Sterling business, our history, our facilities and our company ethos.

For more information, or to speak to a member of the Sterling team, please get in touch.